News

Healthtech platform Thermofy, the developers of FeverFy, partners with Hix Group to bring the science of screening for epidemics to the U.S. market.

“An examination of (COVID-19) transmission events among cases in Chinese patients outside of Hubei province, China, suggested that 12.6% of transmissions could have occurred before symptom onset in the source patient.” (Presymptomatic Transmission of SARS-CoV-2 -Singapore, January 23-March 16, 2020, Morbidity and Mortality Weekly Report, Centers for Disease Control and Prevention)

What if we could detect the presence of virus before symptom onset?

We could radically restrain the transmission of infectious disease. We could save lives.

What if the “what if” doesn’t have to be a “what if”?

Meet FeverFy.

FeverFy is an A.I. powered thermal imaging technology designed to anticipate fever and identify risk of infection. By capturing a comprehensive thermal image of the face, FeverFy is able to identify individuals with high potential for influenza-like illness prior to the onset of symptoms. Read more

healthtech platform

FeverFy is an artificial intelligence (A.I) powered thermal imaging technology designed to anticipate fever and identify risk of infection.